Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C
Year: 2003
Type: article
Study design: Clinical Trial
Source: Leukemia
Authors: M C Müller, N Gattermann, T Lahaye, M W N Deininger, A Berndt, S Fruehauf, A Neubauer, T Fischer, D K Hossfeld, F Schneller, S W Krause, C Nerl, H G Sayer, O G Ottmann, C Waller, W Aulitzky, P le Coutre, M Freund, K Merx, P Paschka, H König, S Kreil, U Berger, H Gschaidmeier, R Hehlmann, A Hochhaus
Institutions: Heidelberg University, University Medical Centre Mannheim, Medizinische Fakultät Mannheim, Düsseldorf University Hospital, Heinrich Heine University Düsseldorf, University Hospital Leipzig, Leipzig University, Technische Universität Dresden, University Hospital Heidelberg, Philipps University of Marburg, Johannes Gutenberg University Mainz, University Medical Center Hamburg-Eppendorf, Technical University of Munich, University Hospital Regensburg, University of Regensburg, München Klinik Bogenhausen, München Klinik Schwabing, München Klinik, Jena University Hospital, Friedrich Schiller University Jena, Goethe University Frankfurt, University Hospital Frankfurt, University of Freiburg, University Medical Center Freiburg, Robert Bosch Hospital, Stiftung Charité, Charité - Universitätsmedizin Berlin, Universitätsmedizin Rostock, University of Rostock, Novartis (Germany)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2011672574